{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:18:30Z","timestamp":1790000310433,"version":"4.0.1"},"reference-count":82,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"publisher","award":["SF24\/001\/A"],"award-info":[{"award-number":["SF24\/001\/A"]}],"id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"publisher"}]},{"award":["SF24\/001\/A"],"award-info":[{"award-number":["SF24\/001\/A"]}],"id":[{"id":"https:\/\/ror.org\/009p8zv69","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Glucose handling in hepatocyte-derived cells integrates insulin-responsive AKT signaling with GLUT1-mediated glucose transport, jointly regulating substrate trafficking, glycogen synthesis, and cell survival. MK-2206, a potent allosteric AKT inhibitor, and BAY-876, a highly selective GLUT1 inhibitor, represent targeted approaches to disrupt these processes. However, the consequences of simultaneous inhibition of both nodes in hepatocyte-derived cells remain incompletely understood. Objective: This study aims to evaluate the impact of simultaneous AKT inhibition and GLUT1 blockade on target engagement, cell viability, proliferation, cell death, glucose uptake, and glycogen storage in HepG2 cells. Methods: HepG2 cells were treated with MK-2206, BAY-876, or their combination under basal hyperglycemic and acute insulin-challenged conditions. Multi-model synergy, AKT\/GLUT1 pharmacological effects, cell viability, proliferation, cell death, glucose uptake, and glycogen storage were assessed, alongside exploratory molecular docking analyses of both inhibitors against their respective targets. Results: Dual AKT and GLUT1 inhibition produced combination-specific reductions in cell viability and showed a pattern of concurrent antiproliferative effects and increased Annexin V\/PI positivity without detectable caspase-3 activation under insulin-challenged conditions. Furthermore, the dual inhibition of AKT signaling and GLUT1-mediated glucose uptake produced combination-specific reductions in basal glycogen content, while glucose uptake reductions showed AKT-dominant patterns without significant combination superiority over MK-2206 alone under either metabolic state. Exploratory molecular docking of MK-2206 and BAY-876 against AKT1 and SLC2A1\/GLUT1, respectively, generated computationally predicted binding poses consistent with the established binding modes of these inhibitors. Conclusions: Dual AKT\/GLUT1 targeting produces endpoint-specific patterns of pharmacological interaction on insulin-responsive metabolism, proliferation, and cell death in HepG2 hepatocyte-derived cells, distinguishing combination-specific effects from AKT-driven effects. These findings support an endpoint-specific pharmacological framework in which AKT signaling and BAY-876-mediated GLUT1 pharmacological effects jointly influence glucose handling and cell fate in a hepatocyte-derived model.<\/jats:p>","DOI":"10.3390\/biomedicines14092133","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:50:03Z","timestamp":1789995003000},"page":"2133","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells"],"prefix":"10.3390","volume":"14","author":[{"given":"Abutaleb","family":"Asiri","sequence":"first","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"given":"Abeer Al","family":"Otaibi","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4811-2154","authenticated-orcid":false,"given":"Munazzah","family":"Tasleem","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Applied Medical Sciences in Al-Namas, University of Bisha, Al-Namas City 67714, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Sindiyan","family":"Al Shaikh Mubarak","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0574-397X","authenticated-orcid":false,"given":"Muwadah Al","family":"Said","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3280-6882","authenticated-orcid":false,"given":"Yara Al","family":"Mihmadi","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Badr Al","family":"Subei","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6304-2943","authenticated-orcid":false,"given":"Abdulaziz","family":"Asiri","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, 255, Al Nakhil, Bisha 67714, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"}]},{"given":"Ali Al","family":"Qarni","sequence":"additional","affiliation":[{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5434-1976","authenticated-orcid":false,"given":"Ahmed","family":"Bakillah","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center (KAIMRC), Eastern Region, Al Ahsa 36428, Saudi Arabia"},{"name":"Division of Medical Research Core, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Al Ahsa 36428, Saudi Arabia"},{"name":"King Abdulaziz Hospital, Ministry of National Guard-Health Affairs (MNG-HA), Al Ahsa 36428, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Asiri, A., Al Qarni, A., and Bakillah, A. (2024). The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights. Diagnostics, 14.","DOI":"10.20944\/preprints202408.1919.v2"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tsay, A., and Wang, J.C. (2023). The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612665"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Amin, N., Anwar, J., Sulaiman, A., Naumova, N.N., and Anwar, N. (2025). Hepatocellular Carcinoma: A Comprehensive Review. Diseases, 13, Erratum in Diseases\u00a02025, 13, 257. https:\/\/doi.org\/10.3390\/diseases13080257.","DOI":"10.3390\/diseases13080257"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/a-2289-2298","article-title":"Molecular Genealogy of Metabolic-associated Hepatocellular Carcinoma","volume":"44","author":"Kodama","year":"2024","journal-title":"Semin. Liver Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"100305","DOI":"10.1016\/j.jhepr.2021.100305","article-title":"Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"3","author":"Younossi","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/JHC.S283840","article-title":"Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma","volume":"9","author":"Uribe","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.21037\/hbsn.2019.08.08","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease\u2014A review of an emerging challenge facing clinicians","volume":"10","author":"Geh","year":"2021","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","article-title":"Metabolic reprogramming in hepatocellular carcinoma: Mechanisms and therapeutic implications","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhao, X., An, X., Yang, C., Sun, W., Ji, H., and Lian, F. (2023). The crucial role and mechanism of insulin resistance in metabolic disease. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1149239"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4093\/dmj.2021.0280","article-title":"Insulin Resistance: From Mechanisms to Therapeutic Strategies","volume":"46","author":"Lee","year":"2022","journal-title":"Diabetes Metab. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1111\/liv.12903","article-title":"Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma","volume":"35","author":"Chettouh","year":"2015","journal-title":"Liver Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e70132","DOI":"10.1111\/eci.70132","article-title":"Metabolic dysfunction-associated steatotic liver disease, insulin resistance and hepatocellular carcinoma: A deadly triad","volume":"56","author":"Caturano","year":"2025","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.2337\/diabetes.53.12.3048","article-title":"Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes","volume":"53","author":"Krssak","year":"2004","journal-title":"Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1078-0432.CCR-08-1253","article-title":"Mechanism and management of AKT inhibitor-induced hyperglycemia","volume":"15","author":"Crouthamel","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/DMSO.S48260","article-title":"Akt\/PKB activation and insulin signaling: A novel insulin signaling pathway in the treatment of type 2 diabetes","volume":"7","author":"Mackenzie","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Tian, L.-Y., Smit, D.J., and J\u00fccker, M. (2023). The Role of PI3K\/AKT\/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032652"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Mroweh, M., Roth, G., Decaens, T., Marche, P.N., Lerat, H., and Macek J\u00edlkov\u00e1, Z. (2021). Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22041794"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jss.2014.05.083","article-title":"MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest","volume":"191","author":"Wilson","year":"2014","journal-title":"J. Surg. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15293","DOI":"10.1007\/s00432-023-05277-x","article-title":"Inhibitors of the PI3K\/AKT\/mTOR pathway in human malignancies; trend of current clinical trials","volume":"149","author":"Delshad","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11859","DOI":"10.2147\/IJN.S534976","article-title":"Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications","volume":"20","author":"Ren","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"16875","DOI":"10.18632\/oncotarget.15171","article-title":"Glucose transporter GLUT1 expression and clinical outcome in solid tumors: A systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bbamem.2007.11.015","article-title":"GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor","volume":"1778","author":"Takanaga","year":"2008","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"43356","DOI":"10.18632\/oncotarget.17445","article-title":"The prognostic value of GLUT1 in cancers: A systematic review and meta-analysis","volume":"8","author":"Yu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbcan.2012.12.004","article-title":"Expression of glucose transporters in cancers","volume":"1835","author":"Szablewski","year":"2013","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Li, Y.-L., Weng, H.-C., Hsu, J.-L., Lin, S.-W., Guh, J.-H., and Hsu, L.-C. (2019). The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01311"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Weng, H.-C., Sung, C.-J., Hsu, J.-L., Leu, W.-J., Guh, J.-H., Kung, F.-L., and Hsu, L.-C. (2022). The Combination of a Novel GLUT1 Inhibitor and Cisplatin Synergistically Inhibits Breast Cancer Cell Growth by Enhancing the DNA Damaging Effect and Modulating the Akt\/mTOR and MAPK Signaling Pathways. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.879748"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.7150\/jca.21035","article-title":"Combined Inhibitions of Glycolysis and AKT\/autophagy Can Overcome Resistance to EGFR-targeted Therapy of Lung Cancer","volume":"8","author":"Ye","year":"2017","journal-title":"J. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"32667","DOI":"10.18632\/oncotarget.25994","article-title":"Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells","volume":"9","author":"Suzuki","year":"2018","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cmdc.201600276","article-title":"Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876","volume":"11","author":"Siebeneicher","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yang, H., Zhang, M.-Z.-H., Sun, H.-W., Chai, Y.-T., Li, X., Jiang, Q., and Hou, J. (2021). A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.783194"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ma, Y., Wang, W., Idowu, M.O., Oh, U., Wang, X.-Y., Temkin, S.M., and Fang, X. (2018). Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876. Cancers, 11.","DOI":"10.3390\/cancers11010033"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41420-024-02106-z","article-title":"GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells","volume":"10","author":"Miller","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tbcr-24-29","article-title":"Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy","volume":"5","author":"Han","year":"2024","journal-title":"Transl. Breast Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1964732","DOI":"10.1155\/2023\/1964732","article-title":"In Vitro Insulin Resistance Model: A Recent Update","volume":"2023","author":"Yudhani","year":"2023","journal-title":"J. Obes."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","article-title":"Culture and Functional Characterization of Human Hepatoma HepG2 Cells","volume":"Volume 1250","author":"Donato","year":"2015","journal-title":"Protocols in In Vitro Hepatocyte Research"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00709-025-02076-8","article-title":"Glucose consumption and uptake in HepG2 cells is improved by aqueous extracts from leaves, but not rhizomes, of Posidonia oceanica (L.) Delile via GLUT-4 upregulation","volume":"262","author":"Abruscato","year":"2025","journal-title":"Protoplasma"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Asiri, A., Tasleem, M., Al Said, M., Asiri, A., Al Qarni, A.A., and Bakillah, A. (2025). Optimizing Cell Density and Unveiling Cytotoxic Profiles of DMSO and Ethanol in Six Cancer Cell Lines: Experimental and In Silico Insights. Methods Protoc., 8.","DOI":"10.3390\/mps8040093"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.18632\/oncotarget.1236","article-title":"The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy","volume":"4","author":"Simioni","year":"2013","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dong, J., Zhai, B., Sun, W., Hu, F., Cheng, H., and Xu, J. (2017). Activation of phosphatidylinositol 3-kinase\/AKT\/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0185088"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40170-023-00310-6","article-title":"BMP4 upregulates glycogen synthesis through the SMAD\/SLC2A1 (GLUT1) signaling axis in hepatocellular carcinoma (HCC) cells","volume":"11","author":"Zhong","year":"2023","journal-title":"Cancer Metab."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Ghasemi, M., Turnbull, T., Sebastian, S., and Kempson, I. (2021). The MTT Assay: Utility, Limitations, Pitfalls, and Interpretation in Bulk and Single-Cell Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222312827"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"van Tonder, A., Joubert, A.M., and Cromarty, A.D. (2015). Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res. Notes, 8.","DOI":"10.1186\/s13104-015-1000-8"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: An interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s44386-025-00034-1","article-title":"A review of deep learning approaches for drug synergy prediction in cancer","volume":"2","author":"Li","year":"2025","journal-title":"npj Drug Discov."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Al Otaibi, A., Al Shaikh Mubarak, S., Al Hejji, F., Almasaud, A., Al Jami, H., Iqbal, J., Al Qarni, A., Harbi, N.K.A., and Bakillah, A. (2024). Thapsigargin and Tunicamycin Block SARS-CoV-2 Entry into Host Cells via Differential Modulation of Unfolded Protein Response (UPR), AKT Signaling, and Apoptosis. Cells, 13.","DOI":"10.3390\/cells13090769"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"180147","DOI":"10.1098\/rsob.180147","article-title":"Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression","volume":"8","author":"Sefried","year":"2018","journal-title":"Open Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1158\/0008-5472.CAN-14-0803","article-title":"Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells","volume":"74","author":"Bae","year":"2014","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00125-010-1760-6","article-title":"Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling","volume":"53","author":"Sciacca","year":"2010","journal-title":"Diabetologia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1016\/j.celrep.2017.11.085","article-title":"Dynamic Metabolomics Reveals that Insulin Primes the Adipocyte for Glucose Metabolism","volume":"21","author":"Krycer","year":"2017","journal-title":"Cell Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Hung, H.-C., Li, L.-C., Guh, J.-H., Kung, F.-L., and Hsu, L.-C. (2022). Discovery of New Glucose Uptake Inhibitors as Potential Anticancer Agents by Non-Radioactive Cell-Based Assays. Molecules, 27.","DOI":"10.3390\/molecules27228106"},{"key":"ref_55","first-page":"D271","article-title":"The RCSB protein data bank: Integrative view of protein, gene and 3D structural information","volume":"45","author":"Rose","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Wu, W.-I., Voegtli, W.C., Sturgis, H.L., Dizon, F.P., Vigers, G.P.A., and Brandhuber, B.J. (2010). Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition. PLoS ONE, 5.","DOI":"10.2210\/pdb3o96\/pdb"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hsu, K.-C., Chen, Y.-F., Lin, S.-R., and Yang, J.-M. (2011). IGEMDOCK: A graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis. BMC Bioinform., 12.","DOI":"10.1186\/1471-2105-12-S1-S33"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem substance and compound databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.7150\/ijbs.89942","article-title":"The PI3K\/Akt Pathway and Glucose Metabolism: A Dangerous Liaison in Cancer","volume":"20","author":"Fontana","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_62","first-page":"63","article-title":"Influence and treatment of insulin receptor substrate\/PI3K\/Akt-mediated insulin resistance in diabetes mellitus (Review)","volume":"33","author":"Tang","year":"2026","journal-title":"Mol. Med. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","article-title":"Insulin-PI3K signalling: An evolutionarily insulated metabolic driver of cancer","volume":"16","author":"Hopkins","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00424-020-02417-x","article-title":"Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease","volume":"472","author":"Chadt","year":"2020","journal-title":"Pfl\u00fcg. Arch.-Eur. J. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo","volume":"9","author":"Hirai","year":"2010","journal-title":"Mol. Cancer Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-017-0648-1","article-title":"ROS signaling under metabolic stress: Cross-talk between AMPK and AKT pathway","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Cancer"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","article-title":"AKT\/PKB Signaling: Navigating the Network","volume":"169","author":"Manning","year":"2017","journal-title":"Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR Signaling in Growth, Metabolism, and Disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11010-013-1737-0","article-title":"MK-2206 induces cell cycle arrest and apoptosis in HepG2 cells and sensitizes TRAIL-mediated cell death","volume":"382","author":"Jiao","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"ref_70","first-page":"4204","article-title":"Reduction in the expression of glucose transporter protein GLUT 2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT 1 in late stages of hepatocarcinogenesis","volume":"53","author":"Grobholz","year":"1993","journal-title":"Cancer Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"17937","DOI":"10.1074\/jbc.272.29.17937","article-title":"Role of the GLUT 2 glucose transporter in the response of the L-type pyruvate kinase gene to glucose in liver-derived cells","volume":"272","author":"Antoine","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.lfs.2013.10.011","article-title":"Hepatocyte nuclear factors 1\u03b1\/4\u03b1 and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats","volume":"93","author":"Freitas","year":"2013","journal-title":"Life Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cmet.2007.03.001","article-title":"Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane","volume":"5","author":"Sano","year":"2007","journal-title":"Cell Metab."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Song, L., Li, Y., and Xu, M. (2024). Exogenous Nucleotides Ameliorate Insulin Resistance Induced by Palmitic Acid in HepG2 Cells through the IRS-1\/AKT\/FOXO1 Pathways. Nutrients, 16.","DOI":"10.3390\/nu16121801"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5114\/ceh.2023.127849","article-title":"Increased hepatic Akt phosphorylation alleviated glucose intolerance and improved liver function in leptin-deficient mice","volume":"9","author":"Adar","year":"2023","journal-title":"Clin. Exp. Hepatol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Li, X., Hu, S., Cai, Y., Liu, X., Luo, J., and Wu, T. (2024). Revving the engine: PKB\/AKT as a key regulator of cellular glucose metabolism. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1320964"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.cellsig.2013.11.007","article-title":"Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance","volume":"26","author":"Sylow","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Alemi, M., Oliveira, \u00c2., Tavares, S.C., Vieira, J.R., Alves, M.G., Oliveira, P.F., and Cardoso, I. (2021). Exploring the Physiological Role of Transthyretin in Glucose Metabolism in the Liver. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116073"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2007.08.013","article-title":"Glycogen synthase kinase 3\u03b1-specific regulation of murine hepatic glycogen metabolism","volume":"6","author":"MacAulay","year":"2007","journal-title":"Cell Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/BJ20120772","article-title":"A novel PKB\/Akt inhibitor, MK-2206, effectively inhibits insulin-stimulated glucose metabolism and protein synthesis in isolated rat skeletal muscle","volume":"447","author":"Lai","year":"2012","journal-title":"Biochem. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1038\/s41598-020-68721-9","article-title":"Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype","volume":"10","author":"Molinaro","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.humpath.2009.07.003","article-title":"Hep G2 is a hepatoblastoma-derived cell line","volume":"40","author":"Cheung","year":"2009","journal-title":"Hum. Pathol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/9\/2133\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:40:19Z","timestamp":1789998019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/9\/2133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":82,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["biomedicines14092133"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14092133","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]}}}